Post by Swiss Cancer Institute

Over the past days, our team has had the opportunity to engage with researchers, clinicians, and industry experts from around the world, all united by a common goal: advancing cancer research and improving outcomes for patients.    The American Society of Clinical Oncology (ASCO) Annual Meeting offers a unique platform for scientific exchange, collaboration, and the discussion of the latest developments in oncology. From thought-provoking sessions to inspiring conversations, the meeting continues to highlight the importance of international cooperation in bringing innovative treatments to patients.    We are proud to contribute to these discussions through our own research and to represent the Swiss Cancer Institute within the global oncology community.    A big thank you to everyone who has connected with us so far. We look forward to sharing key takeaways and updates from our presentations in the coming days. Jan-Henrik Terwey, Claudia Morf, Roch-Philippe Charles, Katrin Eckhardt, Prof. Dr. Roger von Moos, Markus Joerger MD-PhD ClinPharm, José L. Sandoval